TargetMol

Tripartin

Product Code:
 
TAR-T29014
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T29014-5mg5mg£850.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
Tripartin specifically inhibits the histone H3 lysine 9 demethylase KDM4 in HeLa cells.
CAS:
1428962-73-5
Formula:
C10H8Cl2O4
Molecular Weight:
263.07
Purity:
0.98
SMILES:
Oc1cc2C(=O)C[C@@](O)(C(Cl)Cl)c2c(O)c1

References

1. Ageta-Ishihara N, Konno K, Yamazaki M, Abe M, Sakimura K, Watanabe M, Kinoshita M. CDC42EP4, a perisynaptic scaffold protein in Bergmann glia, is required for glutamatergic tripartite synapse configuration. Neurochem Int. 2018 Jan 9. pii: S0197-0186(17)30442-4. doi: 10.1016/j.neuint.2018.01.003. [Epub ahead of print] PubMed PMID: 29330091. 2. Prior KM, Palmer TM. Economy of scale: third partner strengthens a keystone ant-plant mutualism. Ecology. 2018 Jan 12. doi: 10.1002/ecy.2104. [Epub ahead of print] PubMed PMID: 29328512. 3. Daum H, Lerer I, Frumkin A, Rosenak D, Yanai N, Porat S, Yagel S, Meiner V. Ultrasound findings provide clues to investigate founder mutations expressed as runs of homozygosity in chromosomal microarray studies. Prenat Diagn. 2018 Jan 11. doi: 10.1002/pd.5201. [Epub ahead of print] PubMed PMID: 29327352. 4. Tang SL, Gao YL, Wen-Zhong H. Knockdown of TRIM37 suppresses the proliferation, migration and invasion of glioma cells through the inactivation of PI3K/Akt signaling pathway. Biomed Pharmacother. 2018 Jan 8;99:59-64. doi: 10.1016/j.biopha.2018.01.054. [Epub ahead of print] PubMed PMID: 29324313.